ARCHIVES

Arimidex Gets Full Approval For HR+ Early Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 9 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

NCAB Commends Garb for His Contributions

December 11, 1981

Interactive R01 Scores Vary widely, Result Of separate Review

June 11, 1993

FDA Ponders Standards For “Retrospective Prospective” Studies

January 30, 2009

Advisors Approve NCI Plan To Contract For Early Clinical Trials Of Imaging Agents.

March 31, 2000

Cancer Policy: New Cancer Board to Take A Year to Conduct First Study

April 18, 1997

In Brief: Hellman To Head DCT board; Gard Joins Colorado Group; NCI May Support Death Index

September 12, 1980